Transcode Therapeutics, Inc.
RNAZ- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001829635
No open-market purchases or sales by Transcode Therapeutics, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $208.1K in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Transcode Therapeutics, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 5 | 19 | +14 |
| Shares | 9.91K | 2.14M | +2.13M (+21,506.5%) |
| Value | $33.4K | $1.06M | +$1.03M (+3,074.1%) |
New holders (14)
Institutions that held Transcode Therapeutics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Anson Funds Management LP | 1,462,112 | $723.7K | 0.17% |
| Sabby Management, LLC | 229,052 | $113.4K | 0.48% |
| Warberg Asset Management LLC | 50,000 | $24.8K | 0.01% |
| Corsair Capital Management, L.P. | 40,000 | $19.8K | 0.01% |
| Commonwealth Equity Services, LLC | 21,674 | $11.0K | 0.00% |
| Acadian Asset Management LLC | 22,323 | $11.0K | 0.00% |
| South State Corp. | 18,010 | $8.91K | 0.00% |
| Ground Swell Capital, LLC | 14,363 | $7.11K | 0.02% |
| Marex Group plc | 12,678 | $6.28K | 0.00% |
| SBI Securities Co., Ltd. | 374 | $185 | 0.00% |
| Advisor Group Holdings, Inc. | 100 | $50 | 0.00% |
| FMR LLC | 25 | $12 | 0.00% |
| Royal Bank of Canada | 250 | $0 | 0.00% |
| BlackRock, Inc. | 1 | $0 | 0.00% |
Sold out (0)
Institutions that held Transcode Therapeutics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
None.